CP 690550 - Tasocitinib | Tofacitinib

Based on 772 publications in PubMed 10 10 772

Axon 1338

CAS [477600-75-2]

MF C16H20N6O
MW 312.37

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO

CP 690550

Description

Janus Kinase 3 (JAK3) inhibitor; an immunosuppressive agent exhibiting potent effects in preclinical transplantation and arthritis models; clinically safe and effective in preventing transplant rejection and improving symptoms of rheumatoid arthritis and psoriasis.
This product is also available as its citrate salt form, Tofacitinib citrate (Axon 2072). 

KEYWORDS: CP 690550 | supplier | JAK3 inhibitor | Tasocitinib | Tofacitinib | CP690550 | CP-690550 | CAS [477600-75-2] | JAK-STAT Pathway | JAK | Janus Kinase | immunosuppressive | transplantation | rheumatoid | arthritis | rejection | psoriasis

Order
Size Unit Price Stock
2 mg €70.00 In Stock
5 mg €105.00 In Stock
25 mg €350.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €160.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...